Placental site trophoblastic tumor (PSTT): a case report and review of the literature.


Journal

Pathologica
ISSN: 1591-951X
Titre abrégé: Pathologica
Pays: Italy
ID NLM: 0401123

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 15 04 2023
accepted: 17 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: ppublish

Résumé

Placental site trophoblastic tumor (PSTT), also known as atypical choriocarcinoma, syncytioma, chorioepitheliosis or trophoblastic pseudotumor, is a rare gestational trophoblastic disease (0.25-5% of all trophoblastic tumors) and it is composed by neoplastic proliferation of intermediate trophoblasts at placental implantation site. It consists of aggregates or sheets of large, polyhedral to round, predominantly mononucleated cells with a characteristic vascular and myometrial invasion. Main differential diagnoses are gestational choriocarcinoma (GC) and epitelioid trophoblastic tumor (ETT). We present a case of PSTT in a 25-year-old woman. Neoplastic cells showed moderate/high nuclear pleomorphism, abundant amphophilic, eosinophilic and clear cytoplasm, numerous mitotic figures (10 mitoses/10 HPF), and myometrial invasion. Other features are necrosis, vascular invasion with replacement of myometrial vessels by tumor cells and hemorrhage. The patient showed typical low serum β-hCG levels and high serum humane placental lactogen (hPL) levels.

Identifiants

pubmed: 37114629
doi: 10.32074/1591-951X-873
pmc: PMC10462996
doi:

Substances chimiques

Chorionic Gonadotropin 0

Types de publication

Review Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-116

Informations de copyright

Copyright © 2023 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.

Références

Curr Opin Obstet Gynecol. 2021 Feb 1;33(1):7-12
pubmed: 33337613
J Family Med Prim Care. 2020 Mar 26;9(3):1287-1295
pubmed: 32509606
Front Oncol. 2019 Nov 28;9:937
pubmed: 31850188
Radiol Oncol. 2022 Oct 27;56(4):430-439
pubmed: 36286620
Arch Pathol Lab Med. 2019 Jan;143(1):65-74
pubmed: 30407075

Auteurs

Claudia Zampacorta (C)

Center for Advanced Studies and Technology (CAST), University Chieti-Pescara, Italy.

Maria Paola Pasciuto (MP)

Center for Advanced Studies and Technology (CAST), University Chieti-Pescara, Italy.

Benedetta Ferro (B)

Center for Advanced Studies and Technology (CAST), University Chieti-Pescara, Italy.

Alessandro Lucidi (A)

Department of Obstetrics and Gynecology University of Chieti, Italy.

Angel Sanchez Maestro (AS)

Hospithal Vithas Medimar, Alicante, Spain.

Inigo Espinosa (I)

Department of Pathology, Hospital de la Santa Creu i Sant Pau, Institute of Biomedical Research (IIB Sant Pau), Autonomous University of Barcelona, Barcelona, Spain.

Emanuela D'Angelo (E)

Center for Advanced Studies and Technology (CAST), University Chieti-Pescara, Italy.
Department of Medical, Oral, and Biotechnological Sciences University "G. D'Annunzio" of Chieti-Pescara.

Jaime Prat (J)

Department of Pathology, Hospital de la Santa Creu i Sant Pau, Institute of Biomedical Research (IIB Sant Pau), Autonomous University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH